ABSTRACT
Diagnosis is the preliminary step that offers a promising perspective towards treatment of any disease. Alzheimer's disease, the leading cause of dementia, requires timely and early diagnosis to reduce risk effects and provide personalized medical care. Besides the existing diagnosis in Alzheimer's disease, nanotechnology has opened new avenues in imaging and/or detecting the disease's early biomarkers. The development of these diagnostic tools meets a fast-growing frontier and technical challenges. This chapter provides a glimpse of nanotechnology-based approaches in the diagnosis of Alzheimer's disease and the existing gaps between lab research and commercial applications.
